4826 | It has been a while but I am back. | kaiser | 09/28/2025 5:45:13 PM |
4405 | TINO 007 | kaiser | 03/25/2015 10:32:26 AM |
4404 | SREH 0005 hitting | kaiser | 03/25/2015 10:01:10 AM |
4403 | GEQU 0059 | kaiser | 03/25/2015 9:59:04 AM |
4402 | GEQU 0055 | kaiser | 03/25/2015 9:41:03 AM |
4401 | GEQU 005 | kaiser | 03/25/2015 9:36:37 AM |
4400 | GEQU 0039 | kaiser | 03/25/2015 9:33:18 AM |
4399 | LLBO is currently the most undervalued stock of | Golden Ticket | 03/25/2015 1:51:40 AM |
4398 | FLIB 0025 should be a nice bounce play | kaiser | 03/24/2015 10:36:54 PM |
4397 | VOIS 0028 company should have an update about | kaiser | 03/24/2015 10:25:11 PM |
4396 | GEQU 003 nice 8-K filing out today. | kaiser | 03/24/2015 10:20:39 PM |
4395 | SREH 0004 X 0005 company should have a nice | kaiser | 03/24/2015 3:44:00 PM |
4394 | TINO 007 X 008 | kaiser | 03/24/2015 3:14:19 PM |
4393 | TINO 0055 X 0065 | kaiser | 03/24/2015 12:11:49 PM |
4392 | GEQU 0031 | kaiser | 03/24/2015 12:10:02 PM |
4391 | GEQU 0027 X 003 | kaiser | 03/24/2015 11:57:28 AM |
4390 | GEQU 0028 X 0029 | kaiser | 03/24/2015 10:51:26 AM |
4389 | IDVC 0011 X 0012 bid building. | kaiser | 03/24/2015 9:39:57 AM |
4388 | MCGI 0037 setting up very well. Should be a nice | kaiser | 03/22/2015 9:58:04 PM |
4387 | VOIS 003. Company should have nice news coming | kaiser | 03/22/2015 9:54:51 PM |
4386 | GEQU 003 looks ready for a | kaiser | 03/22/2015 9:51:51 PM |
4385 | MGON 0015 | kaiser | 03/17/2015 12:00:38 PM |
4384 | GEQU 005 X 0055 | kaiser | 03/17/2015 11:56:41 AM |
4383 | MGON 0013 X 0014 | kaiser | 03/17/2015 11:45:41 AM |
4382 | MGON 0012 X 0013 | kaiser | 03/17/2015 11:25:42 AM |
4381 | GEQU 006 | kaiser | 03/17/2015 11:10:12 AM |
4380 | MGON 0011 X 0012 | kaiser | 03/17/2015 10:45:11 AM |
4379 | GEQU 0039 X 0043 | kaiser | 03/17/2015 9:49:02 AM |
4378 | GEQU 004 nice news out yesterday. | kaiser | 03/17/2015 9:22:59 AM |
4377 | MGON 0016 looks ready to move over | kaiser | 03/16/2015 11:49:37 AM |
4376 | MCGI 0038 X 0042 | kaiser | 03/13/2015 2:21:06 PM |
4375 | JALA 0085 | kaiser | 03/13/2015 2:02:17 PM |
4374 | JALA 0081 X 0083 | kaiser | 03/13/2015 1:09:33 PM |
4373 | IDVC 0012 buys coming in | kaiser | 03/13/2015 12:30:53 PM |
4372 | JALA 0082 | kaiser | 03/13/2015 12:15:41 PM |
4371 | JALA 0075 X 008 | kaiser | 03/13/2015 11:34:09 AM |
4370 | MCGI 0038 | kaiser | 03/13/2015 11:18:59 AM |
4369 | MCGI 0036 hitting | kaiser | 03/13/2015 11:08:51 AM |
4368 | JALA 0077 | kaiser | 03/13/2015 10:51:33 AM |
4367 | TPAC 0014 | kaiser | 03/13/2015 10:50:43 AM |
4366 | TPAC 0013 | kaiser | 03/13/2015 10:12:49 AM |
4365 | JALA 0076 | kaiser | 03/13/2015 10:12:21 AM |
4364 | VOIS 0044 | kaiser | 03/13/2015 10:11:06 AM |
4363 | VOIS 0043 company should have news coming | kaiser | 03/13/2015 9:53:35 AM |
4362 | TPAC 0012 nice buys coming in | kaiser | 03/13/2015 9:48:03 AM |
4361 | MCGI 0036 | kaiser | 03/13/2015 9:33:13 AM |
4360 | JALA 0065 X 0069 | kaiser | 03/10/2015 1:40:23 PM |
4359 | JALA 0065 | kaiser | 03/10/2015 1:05:58 PM |
4358 | RCGP 0025 X 003 | kaiser | 03/10/2015 1:03:09 PM |
4357 | MCGI 0023 | kaiser | 03/10/2015 11:56:54 AM |
4356 | JALA 0064 X 0066 | kaiser | 03/10/2015 11:16:16 AM |
Recent Articles
- Soleno Therapeutics Faces Investigation Over Securities Practices
- Understanding the Recent Legal Developments Surrounding Lantheus
- Brunello Cucinelli Under Scrutiny Amid Allegations of Misconduct
- Investigation Launched Into Stitch Fix, Inc. by Pomerantz Law
- Investigation Alert: Trinseo PLC Faces Securities Claims
- Investigation into Reddit, Inc.: Potential Securities Fraud Claims
- Investigation into Acadia Pharmaceuticals Amid Legal Concerns
- Nutex Health Under Legal Fire Amid Revenue Inflation Accusations
- Unlocking Efficiency: Affordable Virtual Staffing with VirtuAssist
- Exploring Underrated Stocks: Insights on Market Opportunities
- Investors Alert: Class Action for Brunello Cucinelli S.p.A.
- Unveiling the Future: AI Pavilion Launches at Global Sources
- Sichuan Promotes Cultural Tourism Globally with New Logo
- Vera Bradley Faces Investor Scrutiny Amid Financial Concerns
- Families Carrying On the Haunted Legacy of Frightful Fun
- Understanding Your Rights After Freeport-McMoRan Stock Losses
- NuCana Showcases Promising Results of NUC-7738 in Cancer Therapy
- MorseLife's Recognition: A Testament to Commitment and Care
- Innovative Mutual Finance Attracts Thousands with DeFi Launch
- Exploring the Insights from the CDFG Consumer White Paper 2024-2025
- Latest Market Updates: Stocks Show Mixed Responses Amid Changes
- Investigation Looms Over Guess?, Inc. Merger with Authentic Brands
- Investigating Jefferies Financial Group Inc.: What You Need to Know
- Molina Healthcare Investors: Important Legal Actions Ahead
- Promising Results for Rinatabart Sesutecan in Cancer Treatment
- Nuvalent Unveils Promising Insights on Neladalkib for ALK Cancer
- United Airlines Incident: Tarmac Collision at O'Hare Airport
- Samsung Chairman's Family Sells Shares to Meet Inheritance Tax
- Clinical Breakthrough: ITM's Promising Trial Results Unveiled
- Celcuity's Promising Phase 1 Trial Results on Prostate Cancer Therapy
- New Findings on Gedatolisib’s Efficacy for Advanced Breast Cancer
- Concerns Raised Over Elon Musk's Striking Compensation Package
- Qustodio: Elevating Digital Child Safety on iPhones in 2025
- Celcuity's Phase 3 VIKTORIA-1 Trial for PIK3CA Mutants Advances
- Innovative Gedatolisib and Darolutamide Study Shows Promise
- New Insights on Gedatolisib's Role in Breast Cancer Treatment
- Meta and Blue Owl Collaborate on $30 Billion AI Data Center
- Kura Oncology's Latest Insights on FTI Program Advancements
- Nvidia's Market Share Plummets: CEO Jensen Huang's Concerns
- Kura Oncology Unveils Promising Data from FTI Programs at ESMO
- Olema Oncology Shares Promising Findings on Palazestrant
- General Oncology's SHARON Trial Yields Encouraging Results
- Revitalizing ER+ Breast Cancer with Palazestrant and Ribociclib
- Corbus Pharmaceuticals Reports Promising Results for CRB-701
- Promising Data on NX-1607: A Breakthrough in Cancer Treatment
- Florida Cancer Specialists Revolutionizing Oncology Research
- Salesforce CEO's Apology Sparks Controversy in Tech Industry
- Significant Progress in Advanced Breast Cancer Treatments with Giredestrant
- Breakthrough in HPV Carcinoma Treatment by SCG Cell Therapy
- Innovative Immunotherapy SCG142 Shows Promise in Cancer Treatment